The HDAC inhibitor panobinostat (LBH589) exerts in vivo anti-leukaemic activity against MLL-rearranged acute lymphoblastic leukaemia and involves the RNF20/RNF40/WAC-H2B ubiquitination axis

P. Garrido Castro, E. H.J. Van Roon, S. S. Pinhanços, L. Trentin, P. Schneider, M. Kerstjens, G. Te Kronnie, O. Heidenreich, R. Pieters, R. W. Stam

Onderzoeksoutput: Bijdrage aan tijdschriftArtikelpeer review

48 Citaten (Scopus)

Vingerafdruk

Duik in de onderzoeksthema's van 'The HDAC inhibitor panobinostat (LBH589) exerts in vivo anti-leukaemic activity against MLL-rearranged acute lymphoblastic leukaemia and involves the RNF20/RNF40/WAC-H2B ubiquitination axis'. Samen vormen ze een unieke vingerafdruk.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology